DVA
$149.31-0.45 (-0.30%)
DaVita Inc.
Recent News
DaVita Stock: Is DVA Outperforming the Health Care Sector?
DaVita has outperformed the Health Care sector recently, but analysts are cautious about the stock’s prospects.
DaVita’s Strong Operations Confront Debt Warning And Insider Selling Signals
DaVita (NYSE:DVA) reports strong operational performance with solid revenue growth and expanding margins. The company now faces early warning signals, including a distress-level Altman Z-Score that flags potential financial risk. Recent insider selling activity at DaVita adds another layer of concern for investors tracking internal confidence. DaVita, a major provider of kidney care services, sits at the intersection of aging demographics, chronic disease trends and ongoing pressure on...
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
DGX, DVA, OPCH and ADUS gain attention as telehealth, AI adoption and aging population drive growth in home healthcare services.
DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $149.98, denoting a +1.19% move from the preceding trading day.
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts
An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.